Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Nutra Pharma Corp. (NPHC) had Return on Tangible Equity of 8.68% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$0.39M |
|
$-1.29M |
|
$0.14M |
|
$0.25M |
|
$1.27M |
|
$-0.88M |
|
$-0.41M |
|
$-1.29M |
|
$-1.29M |
|
$-1.29M |
|
$-1.29M |
|
$-1.29M |
|
$-1.29M |
|
$-0.88M |
|
$-0.66M |
|
7.67B |
|
7.67B |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$0.37M |
|
$0.01M |
|
$0.22M |
|
$0.60M |
|
$15.27M |
|
$0.14M |
|
$0.14M |
|
$15.41M |
|
$-14.82M |
|
$-14.81M |
|
$-14.81M |
|
7.10B |
|
| Cash Flow Statement Financials | |
$-0.42M |
|
$0.04M |
|
$0.42M |
|
$0.00M |
|
$0.04M |
|
$0.04M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.02 |
|
-- |
|
-- |
|
-0.01 |
|
-0.58 |
|
63.07% |
|
-224.00% |
|
-224.00% |
|
-167.44% |
|
-327.85% |
|
-327.85% |
|
$-0.42M |
|
-- |
|
-- |
|
-- |
|
0.65 |
|
8.18 |
|
1.44 |
|
254.19 |
|
8.68% |
|
|
Return on Tangible Equity |
8.68% |
-214.46% |
|
8.77% |
|
$-0.00 |
|
$-0.00 |
|
$-0.00 |
|